Inventus Control

R&D

Through Inventus Control, Inventus delivers a dedicated Mobile Device Management (MDM) platform for the life sciences sector.

News

MSD's tulisokibart has become the first anti-TL1A antibody to help patients with ulcerative colitis achieve clinical remission in a phase 3 trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.